Li Ping
Li Ping — Chief Physician — Nephrology — Sino-Japanese Friendship Hospital
Specialties
Integrated Chinese and Western medicine treatment for chronic kidney disease, integrated treatment of chronic renal failure and chronic nephritis proteinuria, diabetic nephropathy
Education
Graduated from Beijing University of Chinese Medicine in 1982, he studied under Professor Shi Zhensheng, a traditional Chinese medicine nephrologist, and obtained a master's and doctoral degree in clinical Chinese internal medicine from the China Academy of Chinese Medical Sciences; he also twice received the Shichuan Medical Scholarship to study at the Nephrology Research Institute of Niigata University School of Medicine in Japan, earning a Doctor of Medicine degree from that university.
Professional Experience
Chief physician, second-level researcher, Qihuang scholar, famous traditional Chinese medicine doctor in the capital, director of the Beijing Key Laboratory of Immune Inflammatory Diseases, and director of the Key Research Office for the Evaluation of Kidney Disease Treatment of the National Administration of Traditional Chinese Medicine. Since June 1999, he has served as a researcher in the Department of Nephrology at the China-Japan Friendship Hospital; in July 2001, he was appointed deputy director of the China-Japan Friendship Institute of Clinical Medicine, concurrently serving as director of the Department of Integrated Traditional Chinese and Western Medicine and Pharmacology.
Professional Roles
Current Vice President of the Nephrology Professional Committee of the World Federation of Chinese Medicine Societies; Deputy Director of the Diabetes Professional Committee of the China Association for the Promotion of Chinese Medicine Research; Director of the Professional Committee for the Development and Research of Chinese Medicine for Nephropathy of the China Association of Chinese Medicine; President of the Professional Committee for Clinical Medication Safety Research of the World Federation of Chinese Medicine Societies.